BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Atavistik Bio Announces Appointment of William Sellers, M.D. to its Scientific Advisory Board

  April 1, 2025

   · 

  3 min read
• Press Releases

  Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives

  April 1, 2025

   · 

  4 min read
• Press Releases

  Remix Therapeutics to Present at Stifel 2025 Virtual Targeted Oncology Forum

  April 1, 2025

   · 

  1 min read
• Press Releases

  Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  April 1, 2025

   · 

  14 min read
• Press Releases

  ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights

  April 1, 2025

   · 

  14 min read
• Press Releases

  Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

  April 1, 2025

   · 

  11 min read
• Press Releases

  Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

  April 1, 2025

   · 

  14 min read
• Press Releases

  ABEC Unveils Breakthrough Single Use Bioreactor Technology for Cell Therapy Manufacturing

  April 1, 2025

   · 

  2 min read
• Press Releases

  Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults

  April 1, 2025

   · 

  4 min read
• Press Releases

  IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

  April 1, 2025

   · 

  19 min read